Jiangyuan Zhou
Member of Yi Ji's pediatric vascular-anomalies and surgical-oncology team; co-author on the sirolimus-for-Kaposiform-hemangioendothelioma study.
West China Hospital, Sichuan University · Pediatric surgical oncology & vascular anomalies
Jiangyuan Zhou is part of Yi Ji's Division of Oncology within Pediatric Surgery at West China Hospital — a high-volume center for pediatric vascular anomalies. The 2026 matched multicentre cohort study co-authored found that head-and-neck Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon responds strongly to sirolimus monotherapy.
The same name appears on dozens of other papers from Yi Ji's West China Hospital pediatric-surgery group, indicating an established, ongoing role on this clinical-research team.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | H | High Responsiveness of Head and Neck Kaposiform Hemangioendothelioma Without Kasabach-Merritt Phenomenon to Sirolimus Monotherapy. XU2026 Co-author on the matched multicentre cohort study showing head-and-neck Kaposiform hemangioendothelioma (without Kasabach-Merritt phenomenon) responds strongly to sirolimus monotherapy. |
Co-authors in the Atlas 2
People with a profile here who share at least one study with Jiangyuan Zhou.
ShowHide
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.